DGAP-News

MPH Mittelständische Pharma Holding AG: Preliminary IFRS results 2012, sales of EUR 205 million, annual net income of EUR 17 million

DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s):
Preliminary Results/Final Results
MPH Mittelständische Pharma Holding AG: Preliminary IFRS results 2012,
sales of EUR 205 million, annual net income of EUR 17 million

08.03.2013 / 11:21

---

Preliminary IFRS results 2012, sales of EUR 205 million, annual net income
of EUR 17 million

Berlin, March, 8, 2013

MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), today
reports its preliminary IFRS Group results for the financial year 2012.

In the financial year 2012, the preliminary IFRS sales amounted to
approximately EUR 205 million and the preliminary IFRS consolidated profit
grew to about EUR 17 million. The preliminary IFRS earnings per share
reached about EUR 0.4.

IFRS Group sales increased by over 40 %, from EUR 145.51 million to around
EUR 205 million compared to the previous year 2011. IFRS consolidated
profit rose by 96 % from EUR 8.65 million to about EUR 17 million.

The Management Board will propose the dividend amount to the Supervisory
Board and the shareholders after the final numbers 2012 have been
established.

´The MPH Group will further expand the segments Pharma and Healthcare in
year 2013. The business success in year 2012 will enable the Group to carry
on with the shareholder-friendly dividend policy´, said Patrick Brenske and
Dr. Christian Pahl, Members of the Management Board of MPH Mittelständische
Pharma Holding AG.

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has
strategically concentrated its activities on the growth segments Pharma and
Healthcare. On the basis of patent-free and patent-protected active
substances, production and consultancy services for therapies of chronic
diseases, the Group makes a precious contribution to keeping health
affordable.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 41.167.155
Listed shares: Preference shares
Number of preference shares in circulation: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock symbol: 93MV

Contact:

Linda Reichelt
MPH Mittelständische Pharma Holding AG
Hubertusallee 73
D-14193 Berlin
Tel:[phone] Fax:[phone]
E-Mail: [e-mail]   Web: www.mph-ag.de

End of Corporate News

---

08.03.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:    English                                                     
Company:     MPH Mittelständische Pharma Holding AG                      
             Hubertusallee 73                                            
             14193 Berlin                                                
             Germany                                                     
Phone:       030 / 897 308 660                                           
Fax:         030 / 897 308 670                                           
E-mail:      [e-mail]                                              
Internet:    www.mph-ag.de                                               
ISIN:        DE000A0NF697                                                
WKN:         A0NF69                                                      
Listed:      Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in  
             Open Market (Entry Standard)                                

End of News    DGAP News-Service  

---

  
203409 08.03.2013